154 related articles for article (PubMed ID: 26595805)
1. Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.
Dykstra KM; Allen C; Born EJ; Tong H; Holstein SA
Oncotarget; 2015 Dec; 6(39):41535-49. PubMed ID: 26595805
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.
Binnington B; Nguyen L; Kamani M; Hossain D; Marks DL; Budani M; Lingwood CA
Glycobiology; 2016 Feb; 26(2):166-80. PubMed ID: 26405105
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant GABARAP deficiency abrogates bortezomib-induced immunogenic cell death in multiple myeloma.
Zhao L; Shen Z; Kroemer G; Kepp O
Oncoimmunology; 2024; 13(1):2360275. PubMed ID: 38812570
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.
Haney SL; Feng D; Chhonker YS; Varney ML; Williams JT; Smith LM; Ford JB; Murry DJ; Holstein SA
Drug Dev Res; 2023 Feb; 84(1):62-74. PubMed ID: 36433690
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and future directions in targeting the secretory apparatus in multiple myeloma.
Auner HW; Cenci S
Br J Haematol; 2015 Jan; 168(1):14-25. PubMed ID: 25296649
[TBL] [Abstract][Full Text] [Related]
6. α-Amino bisphosphonate triazoles serve as GGDPS inhibitors.
Gehrke NR; Feng D; Ayub Ali M; Maalouf MA; Holstein SA; Wiemer DF
Bioorg Med Chem Lett; 2024 Apr; 102():129659. PubMed ID: 38373465
[TBL] [Abstract][Full Text] [Related]
7. A Golgi-Targeted Platinum Complex Plays a Dual Role in Autophagy Regulation for Highly Efficient Cancer Therapy.
Liang BB; Liu Q; Liu B; Yao HG; He J; Tang CF; Peng K; Su XX; Zheng Y; Ding JY; Shen J; Cao Q; Mao ZW
Angew Chem Int Ed Engl; 2023 Oct; 62(44):e202312170. PubMed ID: 37710398
[TBL] [Abstract][Full Text] [Related]
8. Combining Isoprenoid Probes with Antibody Markers for Mass Cytometric Analysis of Prenylation in Single Cells.
Maxwell ZA; Suazo KF; Brown HMG; Distefano MD; Arriaga EA
Anal Chem; 2022 Aug; 94(33):11521-11528. PubMed ID: 35952372
[TBL] [Abstract][Full Text] [Related]
9. A new autophagy-related nomogram and mechanism in multiple myeloma.
Huang H; Li Y; Zhu Z; Liu Y; Wang W; Chen S; Wu X; Wang Y; Chen Y; Lin H; Liang Y; Shu L
Genes Dis; 2024 Sep; 11(5):101120. PubMed ID: 38831978
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms in multiple myeloma drug resistance.
Nikesitch N; Ling SC
J Clin Pathol; 2016 Feb; 69(2):97-101. PubMed ID: 26598624
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions.
Purushothaman A; Bandari SK; Liu J; Mobley JA; Brown EE; Sanderson RD
J Biol Chem; 2016 Jan; 291(4):1652-1663. PubMed ID: 26601950
[TBL] [Abstract][Full Text] [Related]
13. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
Pan Y; Wang H; Tao Q; Zhang C; Yang D; Qin H; Xiong S; Tao L; Wu F; Zhang J; Zhai Z
Leuk Res; 2016 Jan; 40():77-82. PubMed ID: 26597998
[TBL] [Abstract][Full Text] [Related]
14. Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features.
VanValkenburg ME; Pruitt GI; Brill IK; Costa L; Ehtsham M; Justement IT; Innis-Shelton RD; Salzman D; Reddy ES; Godby KN; Mikhail FM; Carroll AJ; Reddy VB; Sanderson RD; Justement LB; Sanders PW; Brown EE
Cancer Causes Control; 2016 Jan; 27(1):81-91. PubMed ID: 26596855
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.
Rosebeck S; Alonge MM; Kandarpa M; Mayampurath A; Volchenboum SL; Jasielec J; Dytfeld D; Maxwell SP; Kraftson SJ; McCauley D; Shacham S; Kauffman M; Jakubowiak AJ
Mol Cancer Ther; 2016 Jan; 15(1):60-71. PubMed ID: 26637366
[TBL] [Abstract][Full Text] [Related]
16. Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.
Suzuki R; Kikuchi S; Harada T; Mimura N; Minami J; Ohguchi H; Yoshida Y; Sagawa M; Gorgun G; Cirstea D; Cottini F; Jakubikova J; Tai YT; Chauhan D; Richardson PG; Munshi N; Ando K; Utsugi T; Hideshima T; Anderson KC
PLoS One; 2015; 10(12):e0143847. PubMed ID: 26630652
[TBL] [Abstract][Full Text] [Related]
17. Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
Bajpai R; Matulis SM; Wei C; Nooka AK; Von Hollen HE; Lonial S; Boise LH; Shanmugam M
Oncogene; 2016 Jul; 35(30):3955-64. PubMed ID: 26640142
[TBL] [Abstract][Full Text] [Related]
18. Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.
Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
Blood Cancer J; 2015 Dec; 5(12):e373. PubMed ID: 26636288
[TBL] [Abstract][Full Text] [Related]
19. Interplay between unfolded protein response and autophagy promotes tumor drug resistance.
Yan MM; Ni JD; Song D; Ding M; Huang J
Oncol Lett; 2015 Oct; 10(4):1959-1969. PubMed ID: 26622781
[TBL] [Abstract][Full Text] [Related]
20. Autophagy in colorectal cancer: An important switch from physiology to pathology.
Burada F; Nicoli ER; Ciurea ME; Uscatu DC; Ioana M; Gheonea DI
World J Gastrointest Oncol; 2015 Nov; 7(11):271-84. PubMed ID: 26600927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
